|
|
|
Insider
Information: |
Bailey K Thomas |
Relationship: |
Chief Financial Officer |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
304,163 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$39,754 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
304,163 |
|
|
Total
Value |
$39,754 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
4
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
-4.0
|
Percentage
Gain/Loss : |
-82.7%
|
-278.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Chief Financial Officer |
2009-08-17 |
0 |
2011-05-12 |
0 |
Premium* |
|
Nanostring Technologies Inc |
NSTG |
Chief Financial Officer |
2024-05-06 |
304,163 |
2019-08-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2020-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,376 |
5,376 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,710 |
13,710 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2021-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,988 |
15,275 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2021-03-15 |
4/A |
OE |
$0.00 |
$0 |
D/D |
5,376 |
20,651 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2021-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,376 |
19,375 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,222 |
8,222 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,709 |
19,928 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2022-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,753 |
24,163 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2022-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,377 |
21,482 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2023-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,050 |
52,583 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,989 |
55,763 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,224 |
63,709 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,073 |
121,461 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2024-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
182,702 |
304,163 |
0 |
- |
|
ANPIQ |
Angiotech Pharmaceuticals... |
Chief Financial Officer |
|
2009-08-17 |
4 |
B |
$1.64 |
$24,600 |
I/I |
15,000 |
15,000 |
1.99 |
- |
|
ANPIQ |
Angiotech Pharmaceuticals... |
Chief Financial Officer |
|
2011-05-12 |
4 |
D |
$1.64 |
$50,089 |
I/I |
(30,000) |
0 |
0 |
- |
|
ANPIQ |
Angiotech Pharmaceuticals... |
Chief Financial Officer |
|
2009-08-18 |
4 |
B |
$1.69 |
$25,489 |
I/I |
15,000 |
30,000 |
1.99 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2023-05-26 |
4 |
B |
$5.76 |
$86,445 |
D/D |
15,000 |
75,388 |
2.74 |
% |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2022-12-13 |
4 |
B |
$8.05 |
$234,746 |
D/D |
29,161 |
48,533 |
2.74 |
% |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2019-08-06 |
4 |
OE |
$8.16 |
$290,700 |
D/D |
35,625 |
35,625 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2019-11-12 |
4 |
OE |
$8.16 |
$48,446 |
D/D |
5,937 |
5,937 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2020-03-10 |
4 |
OE |
$8.16 |
$64,603 |
D/D |
7,917 |
7,917 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2020-05-18 |
4 |
OE |
$8.16 |
$48,446 |
D/D |
5,937 |
9,197 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2020-08-18 |
4 |
OE |
$8.16 |
$48,454 |
D/D |
5,938 |
5,938 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
|
2020-11-18 |
4 |
OE |
$8.16 |
$48,446 |
D/D |
5,937 |
5,937 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|